Results 91 to 100 of about 3,073 (170)

Two Comprehensive Liquid Chromatography High-Resolution Mass Spectrometry (UPLC-MS/MS) Multi-Methods for Real-Time Therapeutic Drug Monitoring (TDM) of Five Novel Beta-Lactams and of Fosfomycin Administered by Continuous Infusion. [PDF]

Pharmaceutics
Trozzi I, Giorgi B, De Paola R, Gatti M, Pea F.   +4 more
europepmc   +1 more source

Novel Antibiotics and Emerging Resistance:&nbsp;<i>In Vitro</i>&nbsp;Activity of Five Antimicrobials Against Intensive Care Unit Isolates from a Turkish Tertiary Care Hospital. [PDF]

Infect Dis Clin Microbiol
Kutlu HH, Akdoğan-Kittana FN, Günaydın B, Özkılıç Y.   +3 more
europepmc   +1 more source

Drug-Drug Interactions in Recently Approved Antibacterials: A Mini Review. [PDF]

Eur J Drug Metab Pharmacokinet
Baccari I, Bergmann F, Zeitlinger M.
europepmc   +1 more source

Correction: Molecular resistance mechanisms to newly approved antibiotics (2017-2025) in WHO priority pathogens. [PDF]

Front Microbiol
Frontiers Production Office.
europepmc   +1 more source

Effectiveness and safety of meropenem-vaborbactam versus ceftazidime-avibactam in multidrug-resistant Gram-negative infections: a systematic review and meta-analysis with trial sequential analysis. [PDF]

Antimicrob Agents Chemother
Mohammad S, Al Namer Y, Rahimeh W, Albalas M, Almangour TA.   +4 more
europepmc   +1 more source

In vivo pharmacokinetic analysis of meropenem/vaborbactam during continuous venovenous haemodialysis

Journal of Antimicrobial Chemotherapy, 2019
Wesley D Kufel, Ambika P Eranki, Kristopher M Paolino, Andrea Call, Christopher D Miller, Bryan T Mogle   +5 more
openaire   +2 more sources

Current progress in antibacterial agents for carbapenem-resistant enterobacterales. [PDF]

Front Pharmacol
Xu W, Shang L, Li X, Yu J, Shen J, Li Y, He Q, Chen L, Wang D, Wei Y, Niu S.   +10 more
europepmc   +1 more source

From bugs to bots: learning infectious diseases in the AI era. [PDF]

Antimicrob Steward Healthc Epidemiol
Rodriguez-Nava G.
europepmc   +1 more source

Targeting carbapenem-resistant and hypervirulent Klebsiella pneumoniae: in vitro evaluation of cefepime/zidebactam, aztreonam/avibactam, imipenem/relebactam, and meropenem/vaborbactam. [PDF]

BMC Infect Dis
Li Y, Li Y, Jia X, Mao H, Li D, Zhang J.
europepmc   +1 more source

TDM-guided meropenem/vaborbactam-based therapy for successful treatment of intra-abdominal and bloodstream infection caused by KPC-producing ceftazidime/avibactam-resistant Klebsiella pneumoniae in a paediatric liver transplant recipient. [PDF]

J Antimicrob Chemother
Mulé G, Coniglione G, Gatti M, Cona A, Di Martino G, Ranucci G, de Ville de Goyet J, Pea F, Mularoni A.   +8 more
europepmc   +1 more source